FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983510040> ?p ?o ?g. }

• W1983510040 endingPage "313" @default.
• W1983510040 startingPage "313" @default.
• W1983510040 abstract "Abnormal uterine bleeding (AUB) is associated with significant direct medical costs and impacts both society and the quality of life for individual women. Heavy menstrual bleeding, a subset of AUB, also referred to as menorrhagia, is defined as menstrual blood loss greater than 80 mL or the patient's perception of excessive blood loss. The newest treatment option available is a novel combination oral contraceptive product containing estradiol valerate (E2V) and dienogest (DNG). As with other combination oral contraceptives, E2V/DNG works primarily by preventing ovulation. However, in contrast with other combination oral contraceptives, it is the progestin component of E2V/DNG that is responsible for endometrial stabilization. Use of E2V/DNG for six months has led to significant reductions in heavy menstrual bleeding with an average 65% reduction in mean blood loss. Approximately half of the women with heavy menstrual bleeding who received E2V/DNG for six months demonstrated an 80% reduction in mean blood loss. Additionally, significant improvements in hematologic indicators (ie, ferritin, hemoglobin, and hematocrit) have been shown. Based on its chemical properties, E2V/DNG may have fewer adverse effects on lipid and glucose metabolism and reduced risk of thromboembolic complications compared with other combination oral contraceptives. This has not yet been shown in clinical trials and until then it should be assumed that E2V/DNG has a safety profile similar to other combination oral contraceptives containing 35 μg or less of ethinyl estradiol. E2V/DNG has been compared with another combination oral contraceptive in healthy women without heavy menstrual bleeding and demonstrated improved bleeding patterns. E2V/DNG has not been compared with the levonorgestrel intrauterine device or other treatments for heavy menstrual bleeding. When compared with some other treatment options for AUB, E2V/DNG provides the added advantage of effective contraception." @default.
• W1983510040 created "2016-06-24" @default.
• W1983510040 creator A5018797001 @default.
• W1983510040 creator A5019566150 @default.
• W1983510040 creator A5052534937 @default.
• W1983510040 creator A5081066684 @default.
• W1983510040 creator A5089915688 @default.
• W1983510040 date "2013-06-01" @default.
• W1983510040 modified "2023-10-05" @default.
• W1983510040 title "Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest" @default.
• W1983510040 cites W1964894170 @default.
• W1983510040 cites W1966995863 @default.
• W1983510040 cites W1976893984 @default.
• W1983510040 cites W1980840918 @default.
• W1983510040 cites W1987244077 @default.
• W1983510040 cites W1991391345 @default.
• W1983510040 cites W2013202936 @default.
• W1983510040 cites W2014431071 @default.
• W1983510040 cites W2021760239 @default.
• W1983510040 cites W2023952454 @default.
• W1983510040 cites W2025633250 @default.
• W1983510040 cites W2028016880 @default.
• W1983510040 cites W2028949333 @default.
• W1983510040 cites W2031730012 @default.
• W1983510040 cites W2032738770 @default.
• W1983510040 cites W2036683659 @default.
• W1983510040 cites W2043734172 @default.
• W1983510040 cites W2046094424 @default.
• W1983510040 cites W2052921012 @default.
• W1983510040 cites W2055120676 @default.
• W1983510040 cites W2065298721 @default.
• W1983510040 cites W2074364609 @default.
• W1983510040 cites W2079008410 @default.
• W1983510040 cites W2079911945 @default.
• W1983510040 cites W2090979444 @default.
• W1983510040 cites W2097904958 @default.
• W1983510040 cites W2101962667 @default.
• W1983510040 cites W2102492167 @default.
• W1983510040 cites W2107885242 @default.
• W1983510040 cites W2125950103 @default.
• W1983510040 cites W2138150915 @default.
• W1983510040 cites W2143212684 @default.
• W1983510040 cites W2153439743 @default.
• W1983510040 cites W2155624681 @default.
• W1983510040 cites W2172229479 @default.
• W1983510040 cites W2418241203 @default.
• W1983510040 doi "https://doi.org/10.2147/ijwh.s31922" @default.
• W1983510040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3684222" @default.
• W1983510040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23788843" @default.
• W1983510040 hasPublicationYear "2013" @default.
• W1983510040 type Work @default.
• W1983510040 sameAs 1983510040 @default.
• W1983510040 citedByCount "10" @default.
• W1983510040 countsByYear W19835100402014 @default.
• W1983510040 countsByYear W19835100402015 @default.
• W1983510040 countsByYear W19835100402017 @default.
• W1983510040 countsByYear W19835100402018 @default.
• W1983510040 countsByYear W19835100402022 @default.
• W1983510040 crossrefType "journal-article" @default.
• W1983510040 hasAuthorship W1983510040A5018797001 @default.
• W1983510040 hasAuthorship W1983510040A5019566150 @default.
• W1983510040 hasAuthorship W1983510040A5052534937 @default.
• W1983510040 hasAuthorship W1983510040A5081066684 @default.
• W1983510040 hasAuthorship W1983510040A5089915688 @default.
• W1983510040 hasBestOaLocation W19835100401 @default.
• W1983510040 hasConcept C126322002 @default.
• W1983510040 hasConcept C131872663 @default.
• W1983510040 hasConcept C197934379 @default.
• W1983510040 hasConcept C2776607906 @default.
• W1983510040 hasConcept C2777164284 @default.
• W1983510040 hasConcept C2778001906 @default.
• W1983510040 hasConcept C2778239997 @default.
• W1983510040 hasConcept C2779076696 @default.
• W1983510040 hasConcept C2779522080 @default.
• W1983510040 hasConcept C2780186607 @default.
• W1983510040 hasConcept C2781418897 @default.
• W1983510040 hasConcept C2908647359 @default.
• W1983510040 hasConcept C29456083 @default.
• W1983510040 hasConcept C2986817661 @default.
• W1983510040 hasConcept C42407357 @default.
• W1983510040 hasConcept C71924100 @default.
• W1983510040 hasConcept C99454951 @default.
• W1983510040 hasConceptScore W1983510040C126322002 @default.
• W1983510040 hasConceptScore W1983510040C131872663 @default.
• W1983510040 hasConceptScore W1983510040C197934379 @default.
• W1983510040 hasConceptScore W1983510040C2776607906 @default.
• W1983510040 hasConceptScore W1983510040C2777164284 @default.
• W1983510040 hasConceptScore W1983510040C2778001906 @default.
• W1983510040 hasConceptScore W1983510040C2778239997 @default.
• W1983510040 hasConceptScore W1983510040C2779076696 @default.
• W1983510040 hasConceptScore W1983510040C2779522080 @default.
• W1983510040 hasConceptScore W1983510040C2780186607 @default.
• W1983510040 hasConceptScore W1983510040C2781418897 @default.
• W1983510040 hasConceptScore W1983510040C2908647359 @default.
• W1983510040 hasConceptScore W1983510040C29456083 @default.
• W1983510040 hasConceptScore W1983510040C2986817661 @default.
• W1983510040 hasConceptScore W1983510040C42407357 @default.
• W1983510040 hasConceptScore W1983510040C71924100 @default.

• next